An experimental vaccine against coronaviruses, named pEVAC-PS, has successfully completed its first phase of human trials. This vaccine was entirely designed by artificial intelligence. AI
IMPACT Demonstrates AI's capability in accelerating drug discovery and vaccine development, potentially leading to faster responses to future pandemics.
RANK_REASON The cluster reports on the successful completion of early-stage human trials for an AI-designed vaccine, which falls under research milestones. [lever_c_demoted from research: ic=1 ai=1.0]
Read on Mastodon — mastodon.social →
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
